PTEN and cancer: PTEN mutations occurred in 9% (888/10336) of patients in the MSK-IMPACT Clinical Sequencing Cohort, while PTEN was altered in only 5% (534/10194) of patients in China Pan-cancer Cohort (OrigiMed2020) (20, 22).